L'Oréal and Verily announce first-of-its-kind strategic partnership to advance precision skin health
20 Janvier 2022 - 6:00PM
L'Oréal and Verily announce first-of-its-kind strategic partnership
to advance precision skin health
NEWS RELEASE
L’ORÉAL AND VERILY
ANNOUNCE FIRST-OF-ITS-KIND STRATEGIC PARTNERSHIP
TO ADVANCE PRECISION SKIN HEALTH
Clichy,
January 20, 2022
- L'Oréal, the world leader in beauty, and Verily,
an Alphabet precision health company, announced today a strategic
partnership, exclusive in beauty, to advance skin health. The
first-of-its-kind partnership in the beauty industry is expected to
entail two programs aimed to better understand and characterize
skin and hair aging mechanisms and to inform L’Oréal’s precision
beauty tech strategy and product development.
The first is a strategic research collaboration
to establish a longitudinal biological, clinical, environmental
view of skin health. It combines L’Oréal’s deep scientific
knowledge of skin and Verily’s comprehensive clinical science
capabilities, to decode and discover the links between exposome,
skin aging, and deep biology of the skin.
The second is a partnership with Verily’s
R&D Team and L’Oréal’s Active Cosmetics Division, to explore
the development of new technologies and tele-diagnosis solutions
such as sensors, and AI algorithms for dermatology and skincare,
that can form the basis for new services.
“We are excited to partner with Verily, a world
leader in precision health tech. L’Oréal’s century-long
commitment to pioneering innovation has come from our strong belief
in the intersection between science, formulations, and our unique
Advanced Research capabilities to decode revolutionary scientific
discoveries that will create the future of beauty” says
Nicolas Hieronimus, Chief Executive Officer, L’Oréal
Group. “Thanks to this partnership, we want to lead a new
era of skin health, through tech and science, to enable every
person around the world the most inclusive, personalized, powerful
and precise programs for their skin at each stage of their
lives.”
“Verily and L’Oréal believe in the
transformative power of technology to enable precision beauty and
health” says Stephen Gillett, President and COO,
Verily. “We are pleased to partner with a world
leader in cosmetic science to better understand and promote skin
health.”
"We recognize skin health as a critical need for
overall wellness as it not only impacts us physically in our daily
lives, but also holistically. Our collective approach has the
potential to identify the right intervention based on data, powered
by Verily's technology and clinical science abilities combined with
L’Oréal’s beauty industry leading intelligence and dermatology
network" says Brian Otis, Fellow, Co-Founder,
Verily.
“The new partnership between L’Oréal and Verily
promises innovation for dermatologists and consumers. We look
forward to learning more about the skin as a result of their
strategic research collaboration and we hope that the new
algorithms and tools will improve consumer access to personalized
information so people can care for their skin more effectively”
says Dr Amanda Oakley, President, International Society of
Teledermatology.
About L'OréalL’Oréal has
devoted itself to beauty for over 100 years. With its unique
international portfolio of 35 diverse and complementary brands, the
Group generated sales amounting to 27.99 billion euros in 2020 and
employs 85,400 people worldwide. As the world’s leading beauty
company, L’Oréal is present across all distribution networks: mass
market, department stores, pharmacies and drugstores, hair salons,
travel retail, branded retail and e-commerce.Research and
innovation, and a dedicated research team of 4,000 people, are at
the core of L’Oréal’s strategy, working to meet beauty aspirations
all over the world. L’Oréal sets out ambitious sustainable
development goals across the Group for 2030 and aims to empower its
ecosystem for a more inclusive and sustainable society.More
information on https://www.loreal.com/en/mediaroom
"This press release does not constitute an offer
of sale or solicitation of an offer to purchase L'Oréal shares. If
you wish to obtain more comprehensive information about L'Oréal,
please refer to the public documents registered in France with the
Autorité des Marchés Financiers, also available in English on our
website www.loreal-finance.com.This press release may contain
forecast information. While the Company believes that these
statements are based on reasonable assumptions as of the date of
publication of this press release, they are by nature subject to
risks and uncertainties which may lead to a discrepancy between the
actual figures and those indicated or suggested in these
statements.”
CONTACTSL’ORÉALSwitchboard+33
(0)1 47 56 70 00
Individual shareholders and market
regulatorsChristian MUNICH+33 (0)1 47 56 72
06Christian.munich2@loreal.com
Financial analysts and institutional
investorsFrançoise LAUVIN +33 (0)1 47 56 86
82Francoise.lauvin@loreal.com
MediaNoëlle CAMILLERI+33 (0)6 79 92 99
39Noelle.camilleri@loreal.com
Christine BURKE+33 (0)6 75 54 38
15Christine.burke@loreal.com
For further information, please contact your bank,
stockbroker of financial institution (I.S.I.N. code: FR000012031),
and consult your usual newspapers or magazines or the Internet site
for shareholders and investors, www.loreal-finance.com, the L’Oréal
Finance app or call the toll-free number from France: 0 800 66 66
66. 0 800 66 66 66
Follow us on Twitter
@loreal - www.loreal.com
- PR_L’ORÉAL AND VERILY ANNOUNCE FIRST-OF-ITS-KIND STRATEGIC
PARTNERSHIP TO ADVANCE PRECISION SKIN HEALTH
- PHOTO_L'ORÉAL_BIOMETRIC FACIAL RECOGNITION, 3D SCANNING
TECHNOLOGY
- PHOTO_L'ORÉAL_SMART MIRROR CONCEPT
LOreal (EU:OR)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
LOreal (EU:OR)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024